Recent applications of olefin metathesis to combinatorial chemistry

Current Opinion in Chemical Biology

Volumn 8, Issue 3, 2004, Pages 245-254

  Piscopio, Anthony D ^a   Robinson, John E ^a  

^a ARRAY BIOPHARMA INC   (United States)

Author keywords

CM; cross metathesis; MOR; mu opioid receptor; RCM; ring closing metathesis

Indexed keywords

ALCOHOL DERIVATIVE; ALKENE; AZO COMPOUND; BENZOFURAN DERIVATIVE; CARBOHYDRATE; CARBOHYDRATE DERIVATIVE; FAGOMINE; HETEROCYCLIC COMPOUND; LACTAM DERIVATIVE; MANNITOL; PIPERIDINE DERIVATIVE;

CATALYSIS; COMBINATORIAL CHEMISTRY; DIHYDROXYLATION; DRUG SYNTHESIS; EPOXIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGAND BINDING; LYMPHOBLAST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RING CLOSING METATHESIS; SOLID; STEREOCHEMISTRY; TEMPERATURE;

ALKENES; AZIDES; CARBOHYDRATES; CATALYSIS; CHEMISTRY, ORGANIC; COMBINATORIAL CHEMISTRY TECHNIQUES; FURANS; LACTAMS; MODELS, CHEMICAL; ORGANOSILICON COMPOUNDS; PROTEINS; STEREOISOMERISM;

EID: 2942530567     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2004.04.001     Document Type: Review

References (51)

1. Plunkett M.J., Ellman J.A. Combinatorial chemistry and new drugs. Sci Am. 4:1997;68-73
2. Hogan J.C. Jr. Combinatorial chemistry in drug discovery. Nat Biotechnol. 4:1997;328-330
3. Selway C.N., Terrett N.K. Parallel-compound synthesis: methodology for accelerating drug discovery. Bioorg Med Chem. 4:1996;645-654
4. Andres C.J., Whitehouse D.L., Deshpande M.S. Transition-metal-mediated reactions in combinatorial synthesis. Curr Opin Chem Biol. 2:1998;353-362
5. Reetz M.T. Combinatorial methods in catalysis by metal complexes. Comp Coord Chem II. 9:2004;509-548 A review of applications of transition metal catalysis in combinatorial chemistry. In addition, includes discussion of the hit to lead generation process, as well as the importance of screening libraries of catalysts in diversity-based systems.
6. Connon S.J., Blechert S.J. Recent developments in olefin cross-metathesis. Angew Chem Int Ed Engl. 42:2003;1900-1923 A general and comprehensive review of cross-metathesis, including applications to combinatorial synthesis.
7. Fu G., Nguyen S.B.T., Grubbs R.H. Catalytic ring-closing metathesis of functionalized dienes by a ruthenium carbene complex. Chemtracts: Inorg Chem. 2:1996;86-88
8. Grubbs R.H., Miller S.J., Fu G.C. Ring-closing metathesis and related processes in organic synthesis. Acc Chem Res. 11:1995;446-452
9. Furstner A. Ruthenium-catalyzed metathesis reactions in organic synthesis. Top Organomet Chem. 1:1998;37-72
10. 2Ru=CHR Olefin Metathesis Catalysts: An Organometallic Success Story. Acc Chem Res. 34:2001;18-29 The historical development of metathesis reactions, including scope limitations and future direction.
11. Zaragoza F: Olefin metathesis and related processes in combinatorial chemistry multiple bond formation. In Handbook of Combinatorial Chemistry, vol 1. Edited by Nicolaou KC, Hanko R, Hartwig W. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2002:585-609.
12. Clemons P.A. Design and discovery of protein dimerizers. Curr Opin Chem Biol. 1:1999;112-115
13. Nicolaou K.C., Hughes R., Cho S.Y., Winssinger N., Smethurst C., Labischinski H., Endermann R. Target-accelerated combinatorial synthesis and discovery of highly potent antibiotics effective against vancomycin-resistant bacteria. Angew Chem Int Ed Engl. 39:2000;3823-3828
14. Nicolaou K.C., Pfefferkorn J.A., Schuler F., Roecker A.J., Cao G.Q., Casida J.E. Combinatorial synthesis of novel and potent inhibitors of NADH:ubiquinone oxidoreductase. Chem Biol. 12:2000;979-992
15. Burgess L.E., Newhouse B.J., Ibrahim P., Rizzi J., Kashem M.A., Hartman A., Brandhuber B.J., Wright C.D., Thomson D.S., Vigers G.P.A., Koch K. Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA. 96:1999;8348-8352
16. Blackwell H.E., Clemons P.A., Schreiber S.L. Exploiting site-site interactions on solid support to generate dimeric molecules. Org Lett. 3:2001;1185-1188
17. Liao Y., Fathi R., Yang Z. Convergent solid-phase synthesis of symmetrical benzo[b]furan's dimerizer. J Comb Chem. 5:2003;79-81
18. Nicolaou K.C., Pfefferkorn J.A., Mitchell H.J., Roecker A.J., Barluenga S., Cao G.Q., Affleck R.L., Lillig J.E. Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split-and-pool chemistry using NanoKans and optical encoding. J Am Chem Soc. 122:2000;9954-9967
19. Schreiber S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 287:2000;1964-1969
20. Pelish H.E., Westwood N.J., Feng Y., Kirchhausen T., Shair M.D. Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. J Am Chem Soc. 123:2001;6740-6741
21. Zhangje S., Harrison B.A., Verdine G.L. Unpredictable stereochemical preferences for mu opioid receptor activity in an exhaustively stereodiversified library of 1, 4-enediols. Org Lett. 5:2003;633-636
22. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 386:1997;499-502
23. Zadina J.E., Martin-Schild S., Gerall A.A., Kastin A.J., Hackler L., Ge L.J., Zhang X. Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high μ-opiate receptor density. Ann NY Acad Sci. 897:1999;136-144
24. Harrison B.A., Gierasch T.M., Neilan C., Pasternak G.W., Verdine G.L. High-affinity mu opioid receptor ligands discovered by the screening of an exhaustively stereodiversified library of 1, 5-enediols. J Am Chem Soc. 124:2002;13352-13353 The authors discuss the general application of diversity-based library synthesis aimed at targets with unpredictable biological properties. This paper also prompted the development of a cross-metathesis approach to highly hindered allylic alcohol derivatives.
25. Harrison B.A., Pasternak G.W., Verdine G.L. 2, 6-Dimethyltyrosine analogues of a stereodiversified ligand library: highly potent, selective, non-peptidic μ opioid receptor agonists. J Med Chem. 46:2003;677-680
26. Seeberger P.H., Haase W.C. Solid-phase oligosaccharide synthesis and combinatorial carbohydrate libraries. Chem Rev. 100:2000;4349-4393
27. Nyffeler P.T., Liang C.H., Koeller K.M., Wong C.H. The chemistry of amine-azide interconversion: catalytic diazo transfer and regioselective azide reduction. J Am Chem Soc. 124:2002;10773-10778
28. van Boeckel C.A.A., Petitou M. The characteristic AT-III binding region in heparin: an aid in the design of new synthetic antithrombotics. Angew Chem. 105:1993;1741-1761
29. Kanemitsu T., Seeberger P.H. Use of olefin cross-metathesis to release azide-containing sugars from solid support. Org Lett. 5:2003;4541-4544 The authors describe the development of a linker for use in solid phase automated synthesis of masked-amine containing monosaccharides and polysaccharides.
30. Dolle R.E. Comprehensive survey of combinatorial library synthesis: 2001. J Comb Chem. 4:2002;369-418
31. Hirschmann R., Sprengeler P.A., Kawasaki T., Leahy J.W., Shakespeare W.C., Smith A.B. III The versatile steroid nucleus: design and synthesis of a peptidomimetic employing this novel scaffold. Tetrahedron. 49:1993;3665-3676
32. Hirschmann R., Nicolaou K.C., Pietranico S., Leahy E.M., Salvino J., Arison B., Cichy M.A., Spoors P.G., Shakespeare W.C. De novo design and synthesis of somatostatin non-peptide peptidomimetics utilizing alpha-D-glucose as a novel scaffolding. J Am Chem Soc. 115:1993;12550-12568
33. Timmer M.S.M., Verdoes M., Sliedregt L.A.J.M., van der Marel G.A., van Boom J.H., Overkleeft H.S. The use of a mannitol-derived fused oxacycle as a combinatorial scaffold. J Org Chem. 68:2003;9406-9411 Development of a novel scaffold for combinatorial synthesis.
34. Nicolaou K.C., Vourloumis D., Li T., Pastor J., Winssinger N., He Y., Ninkovic S., Sarabia F., Vallberg H., Roschangar F., et al. Designed epothilones: combinatorial synthesis, tubulin assembly properties, and cytotoxic action against taxol-resistant tumor cells. Angew Chem Int Ed Engl. 36:1997;2097-2103
35. Piscopio A.D., Miller J.F., Koch K. Solid phase heterocyclic synthesis via ring closing metathesis: traceless linking and cyclative cleavage through a carbon-carbon double bond. Tetrahedron Lett. 38:1997;7143-7146
36. Koell P., Oelting M. Mono- and dioxetanes of 2, 5-anhydroalditols, syntheses and reactions. Liebigs Ann Chem. 3:1987;205-214
37. van Maarseveen J.H., den Hartog J.A.J., Engelen V., Finner E., Visser G., Kruse C.G. Solid phase ring-closing metathesis: cyclization/cleavage approach towards a seven-membered cycloolefin. Tetrahedron Lett. 37:1996;8249-8252
38. Lillelund V.H., Jensen H.H., Liang X., Bols M. Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin. Chem Rev. 102:2002;515-553
39. Heightman T.D., Vasella A.T. Recent insights into inhibition, structure, and mechanism of configuration-retaining glycosidases. Angew Chem Int Ed Engl. 38:1999;750-770
40. Zechel D.L., Withers S.G. Glycosidase mechanisms: anatomy of a finely tuned catalyst. Acc Chem Res. 33:2000;11-18
41. Stutz AE: Iminosugars as glycosidase inhibitors: Nojirimycin and beyond. Weinheim, Germany: Wiley-VCH; 1999.
42. Asano N., Nash R.J., Molyneux R.J., Fleet G.W.J. Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron Asymmetry. 11:2000;1645-1680
43. Meyers A.I., Andres C.J., Resek J.E., Woodall C.C., McLaughlin M.A., Lee P.H., Price D.A. Asymmetric routes to aza sugars from chiral bicyclic lactams. Synthesis of 1, 4-dideoxy-1, 4-imino-D-lyxitol; L-deoxymannojirimycin; rhammo-1-deoxynojirimycin and 1-deoxy-6-epicastanospermine. Tetrahedron. 55:1999;8931-8952
44. Takahata H., Banba Y., Ouchi H., Nemoto H., Kato A., Adachi I. Asymmetric synthesis of the four possible fagomine isomers. J Org Chem. 68:2003;3603-3607 Discussion of applications of aza-sugars for multiple therapeutic areas, as well a novel general parallel synthesis strategy.
45. Asano N., Nishida M., Kizu H., Matsui K., Watson A.A., Nash R.J. Homonojirimycin isomers and glycosides from Aglaonema treubii. J Nat Prod. 60:1997;98-101
46. Taniguchi S., Asano N., Tomino F., Miwa I. Potentiation of glucose-induced insulin secretion by fagomine, a pseudo-sugar isolated from mulberry leaves. Horm Metab Res. 30:1998;679-683
47. Fan J.Q., Ishii S., Asano N., Suzuki Y. Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med. 5:1999;112-115
48. Dondoni A., Perrone D. Synthesis of 1, 1-dimethylethyl (S)-4-formyl-2, 2-dimethyl-3-oxazolidinecarboxylate by oxidation of the alcohol. Org Syn. 77:2000;64-77 Synthesis of Garner aldehyde.
49. Lamb P., Tapley P., Rosen J. Biochemical approaches to discovering modulators of the JAK-STAT pathway. Drug Discov Today. 3:1998;122-130
50. Piscopio A.D., Miller J.F., Koch K. Ring closing metathesis in organic synthesis: evolution of a high speed, solid phase method for the preparation of β-turn mimetics. Tetrahedron. 55:1999;8189-8198
51. Hoffmann T., Waibel R., Gmeiner P. A general approach to dehydro-freidinger lactams; ex-chiral pool synthesis and spectroscopic evaluation as potential reverse turn inducers. J Org Chem. 68:2003;62-69 Applications of RCM to generate novel β-turn mimetics.